slider img


  Watching for Value and Growth Stocks

  •    Focused on the Mid-250 & Small Cap

  •    Fledgling & AIM     

  •    News & Market Information               

  •    Cambridge Companies


Keeping Local 



Life has been far from easy for Cambridge based medical device company SPHERE since its floatation a few years back.


At a current 24p the shares remain on the sick list, despite having recently gained EU approval for its blood analysing device Proxima.


Having previously shored up the balance sheet via a placing and open offer struck at 40p, the company also cemented a deal with  Johnson & Johnson subsidiary Ortho Clinical Diagnostics, in order to market the device.


However, there are also two other things to note of late aside that welcome news on the approval.

The first, being the purchase of Ortho Diagnostics from J&J by the Carlyle Group for an expected $4bln, which by now should be a done deal.


Such situations understandably unnerve investors, who may well question whether the deal will remain intact under new ownership.


Although that perhaps muddies the water a little, holders will no doubt be content enough by the revelation this morning that Johnson & Johnson’s stake which has now fallen below 3%, appears to have transferred to Ortho Clinical Diagnostics, giving that operation a significant 13% of Sphere.

Given the current market cap now stands at just £14m, the technology which by all counts appears amazingly impressive and has seen a massive amount of investment, is clearly being valued at very little.


Hurdles no doubt remain, but if that relationship remains on track and  develops, assisted by Sphere’s new CEO looking to make his mark, the company may be worth monitoring.

Equally, further progress and positive news flow could well put the shares back on the road to recovery.  


Jenny Chapman business Editor at the Cambridge News is covering the company with a full interview, which should be well worth looking out for in the Cambridge Business Magazine September edition.





And talking of the Magazine, my coverage of BRADY is featured in the current edition from page 40 which may be of interest to some looking in.


This morning it was off to visit  1Spatial here in the City at their HQ across the road from the SciencePark.

It was well worth meeting up with the CEO Marcus Hanke, who very much filled me in on the business and its future prospects. 



Next up for me is SEPURA, where I have a date with the company pencilled in for the 28 June 2014.

Another company that has not only performed well, but continues to do so.




12 August 2014       There has been a Trading Update from PROACTIS HOLDINGS this  morning which appears to have been well received...

Behind The Scenes

Catching Up 12 August 2014       There is no edition of the Cambridge Business Magazine this month, but there are a couple of articles...


UU. 12 August 2014     Despite the ongoing dialogue with Ofwat regarding its business plan and future profits, I have taken a look at UNITED...

Cambridge news

Cambridge news

real logo